Advaxis’ ADXS-HPV Granted Orphan Drug Designation for Treatment of HPV … – 4-traders (press release)

Advaxis' ADXS-HPV Granted Orphan Drug Designation for Treatment of HPV
4-traders (press release)
"We are very pleased to have been granted an orphan drug designation for ADXS-HPV in this unmet medical need," commented Dr. Robert Petit, Chief Scientific Officer of Advaxis. "Patients with anal cancer have limited treatment options and we hope to 

View full post on hpv – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *